Анализ подходов в психотерапевтическом консультировании юношей из группы риска по развитию шизофрении (обзор зарубежной литературы)

Анализ подходов в психотерапевтическом консультировании юношей из группы риска по развитию шизофрении (обзор зарубежной литературы)

 

Авторы

 

Д.Н. Иванов

НКО «Ассоциация когнитивно-поведенческой психотерапии», Санкт-Петербург, Россия; ФГБНУ «Научный центр психического здоровья», Москва, Россия

М.А. Омельченко

ФГБНУ «Научный центр психического здоровья», Москва, Россия

 

https://doi.org/10.26617/1810-3111-2021-1(110)-53-64

 

Журнал:Сибирский вестник психиатрии и наркологии. 2021; 1(110): 53-64.

 

Реферат

На современном этапе совершенствования методов психотерапии особенно актуальны проблемы изучения закономерностей развития, распознавания начальных этапов и психотерапевтически-ориентированной диагностики психических заболеваний, проведения ранних терапевтических вмешательств в отношении такого заболевания, как шизофрения, и её манифестации у больных из группы психотического риска. Это остается одним из самых сложных, перспективных и востребованных направлений в современной медицине. В статье приводится обоснование применения психотерапевтических подходов, форм и методов психотерапии, направленных не только на редукцию симптомов психотического риска и снижение риска манифестации психоза, но и на улучшение уровня социального функционирования. Основное внимание уделяется наиболее распространенному когнитивно-поведенческому методу с подробным рассмотрением его основных протоколов.

 

Ключевые слова:группа риска по шизофрении, подростки мужского пола, когнитивная психотерапия, раннее вмешательство, лечебные протоколы КПТ, профилактика психических расстройств.

 

Статья (pdf)

 

Связь с автором

Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра.

 

Дополнительные материалы

 

Литература

 

  1. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: Systematic review and meta-analysis. BMJ. 2013;346:F185. DOI: 10.1136/bmj.f762.
  2. Bloom, DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein AZ, Weinstein C. The global economic burden of noncommunicable diseases. World Economic Forum, 2011.
  3. Girolamo G, McGorry P, Sartorius N. Age of onset of mental disorders. 2019 Springer International Publishing AG. Switzerland. URL: https://doi.org/10.1007/978-3-319-72619-9
  4. McGlashan TH. Commentary: Progress, issues, and implications of prodromal research: an inside view. Schizophr Bull. 2003;29(4):851-8. doi: 10.1093/oxfordjournals.schbul.a007051
  5. Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, Marin P, Meyer-Lindenberg A, McGorry P, McGuire P, Owen MJ, Patterson P, Sawa A, Spedding M, Uhlhaas P, Vaccarino F, Wahlestedt C, Weinberger D. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016 Jul;15(7):485-515. doi: 10.1038/nrd.2016.28
  6. Fusar-Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry. 2017 Oct;16(3):251-265. doi: 10.1002/wps.20446
  7. Andreou C, Bailey B, Borgwardt S. Assessment and treatment of individuals at high risk for psychosis. BJPsych Advances. 2019;25(3):177-84. URL: https://doi.org/10.1192/bja.2019.3
  8. Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, Perez J, Keri S, Amminger P, Metzler S, Kawohl W, Rössler W, Lee J, Labad J, Ziermans T, An SK, Liu CC, Woodberry KA, Braham A, Corcoran C, McGorry P, Yung AR, McGuire PK. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. JAMA Psychiatry. 2016 Feb;73(2):113-20. doi: 10.1001/jamapsychiatry.2015.2324
  9. Brummitt K, Addington J. Treatment possibilities for individuals at clinical high risk of psychosis. Early Interv Psychiatry. 2013 May;7(2):155-61. doi: 10.1111/j.1751-7893.2012.00370.x
  10. DeVylder JE, Yang LH, Harkavy-Friedman JM, Azimov N, Walder DJ, Corcoran CM. Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures. Psychiatry Res. 2014 Feb 28;215(2):323-8. doi: 10.1016/j.psychres.2013.12.002
  11. Häfner H, an der Heiden W, Maurer K. Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions? Eur Arch Psychiatry Clin Neurosci. 2008 Jun;258 Suppl 2:85-96. doi: 10.1007/s00406-008-2011-4
  12. Fulford D, Niendam TA, Floyd EG, Carter CS, Mathalon DH, Vinogradov S, Stuart BK, Loewy RL. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr Res. 2013 Jun;147(1):125-131. doi: 10.1016/j.schres.2013.03.024
  13. Davies C, Cipriani A, Ioannidis JPA, Radua J, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry. 2018 Jun;17(2):196-209. doi: 10.1002/wps.20526
  14. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry. 2004 Oct;185:291-7. doi: 10.1192/bjp.185.4.291
  15. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res. 2011 Jan;125(1):54-61. doi: 10.1016/j.schres.2010.10.015
  16. Bechdolf A, Wagner M, Veith V, Ruhrmann S, Pukrop R, Brockhaus-Dumke A, Berning J, Stamm E, Janssen B, Decker P, Bottlender R, Moller HJ, Gaebel W, Maier W, Klosterkotter J. Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv Psychiatry. 2007 Feb;1(1):71-8. doi: 10.1111/j.1751-7893.2007.00013.x
  17. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: Systematic review and meta-analysis. BMJ. 2013;346:F.185. doi: 10.1136/bmj.f762.
  18. Thompson A, Broome M. Risk factors for psychosis: Paradigms, mechanisms, and prevention. Academic Press, 2020:456.
  19. Woodberry KA, Shapiro DI, Bryant C, Seidman LJ. Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians. Harv Rev Psychiatry. 2016 Mar-Apr;24(2):87-103. doi: 10.1097/HRP.0000000000000109
  20. Haddock G, Tarrier N, Morrison AP, Hopkins R, Drake R, Lewis S. A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis. Soc Psychiatry Psychiatr Epidemiol. 1999 May;34(5):254-8. doi: 10.1007/s001270050141
  21. Jones C, Hacker D, Meaden A, Cormac I, Irving CB. WITHDRAWN: Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev. 2011 Apr 13;(4): CD000524. doi: 10.1002/14651858.CD000524.pub3
  22. Beck AT. Cognitive therapy and the emotional disorders. New York, NY: International Universities Press, 1976.
  23. Morrison AP, Renton JC, Dunn H, Williams S, Bentall RP. Cognitive therapy for psychosis. A formulation based approach. Hove: Brunner-Routledge, 2004.
  24. Kraepelin E. Psychiatry: A textbook for students and physicans. Vol. 1. General Psychiatry. Canton, MA: Watson Publishing International, 1899/1990.
  25. Zubin J, Spring B. Vulnerability--a new view of schizophrenia. J Abnorm Psychol. 1977 Apr;86(2):103-26. doi: 10.1037//0021-843x.86.2.103
  26. Bentall R.P. Madness Explained. Psychosis and Human Nature. London: Penguin Books, 2003.
  27. CBT for psychosis: A symptom-based approach / еd. by R. Hagen, D. Turkington, T. Berge, R.W. Gråwe. Routledge, 2010:296.
  28. Bentall R. The new psychology and treatment of psychosis. Journal of the Norwegian Psychological Association. 2007;44:524-6.
  29. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001 Feb;31(2):189-95. doi: 10.1017/s0033291701003312
  30. Bentall R.P. Madness explained. Psychosis and human nature. London: Penguin Books, 2003.
  31. Freeman D., Garety P. (eds). Paranoia: The psychology of persecutory delusions. Hove, UK: Psychology Press, 2004. (Maudsley Monograph No. 45.)
  32. Chadwick PD, Lowe CF. Measurement and modification of delusional beliefs. J Consult Clin Psychol. 1990 Apr;58(2):225-32. doi: 10.1037//0022-006x.58.2.225
  33. Watts FN, Powell GE, Austin SV. The modification of abnormal beliefs. Br J Med Psychol. 1973 Dec;46(4):359-63. doi: 10.1111/j.2044-8341.1973.tb02260.x
  34. Drury V, Birchwood M, Cochrane R, Macmillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. Br J Psychiatry. 1996 Nov;169(5):593-601. doi: 10.1192/bjp.169.5.593
  35. Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, Hadley C. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase. Br J Psychiatry. 1997 Oct;171:319-27. doi:  10.1192/bjp.171.4.319
  36. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry. 2000 Feb;57(2):165-72. doi: 10.1001/archpsyc.57.2.165
  37. Tarrier N, Yusupoff L, Kinney C, McCarthy E, Gledhill A, Haddock G, Morris J. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ. 1998 Aug 1;317(7154):303-7. doi:10.1136/bmj.317.7154.303
  38. A clinical introduction to psychosis: Foundations for clinical psychologists / ed. by JC. Badcock, G. Paulik. Academic Press, 2019. 742 p.
  39. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008 May;34(3):523-37. doi: 10.1093/schbul/sbm114
  40. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014 Jan;204(1):20-9. doi: 10.1192/bjp.bp.112.116285
  41. Turner DT, van der Gaag M, Karyotaki E, Cuijpers P. Psychological interventions for psychosis: a meta-analysis of comparative outcome studies. Am J Psychiatry. 2014 May;171(5):523-38. doi: 10.1176/appi.ajp.2013.13081159
  42. Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, Wallis S, Schwermann F, Pitschel-Walz G, Barbui C, Furukawa TA, Leucht S. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018 Oct;17(3):316-329. doi: 10.1002/wps.20577
  43. Burns AM, Erickson DH, Brenner CA. Cognitive-behavioral therapy for medication-resistant psychosis: a meta-analytic review. Psychiatr Serv. 2014 Jul;65(7):874-80. doi: 10.1176/appi.ps.201300213
  44. Thomas N, Hayward M, Peters E, van der Gaag M, Bentall RP, Jenner J, Strauss C, Sommer IE, Johns LC, Varese F, García-Montes JM, Waters F, Dodgson G, McCarthy-Jones S. Psychological therapies for auditory hallucinations (voices): current status and key directions for future research. Schizophr Bull. 2014 Jul;40 Suppl 4(Suppl 4):S202-12. doi: 10.1093/schbul/sbu037
  45. Mehl S, Werner D, Lincoln TM. Does Cognitive Behavior Therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Front Psychol. 2015 Oct 6;6:1450. doi: 10.3389/fpsyg.2015.01450
  46. van der Gaag M, Valmaggia LR, Smit F. The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis. Schizophr Res. 2014 Jun;156(1):30-7. doi: 10.1016/j.schres.2014.03.016
  47. Pyle M, Pilling S, Machin K, Allende-Cullen G, Morrison AP. Peer support for internalised stigma experienced by people with psychosis: Rationale and recommendations. Psychosis. 2018;10(2):146-152. https://doi.org/10.1080/17522439.2018.1437212
  48. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009 Sep;35(5):894-908. doi: 10.1093/schbul/sbp027
  49. Peters E, Landau S, McCrone P, Cooke M, Fisher P, Steel C, Evans R, Carswell K, Dawson K, Williams S, Howard A, Kuipers E. A randomised controlled trial of cognitive behaviour therapy for psychosis in a routine clinical service. Acta Psychiatr Scand. 2010 Oct;122(4):302-18. doi: 10.1111/j.1600-0447.2010.01572.x
  50. Grant P M, Huh GA, Perivoliotis D, Stolar NM, Beck AT. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch Gen Psychiatry. 2012;69(2):121-127. doi:10.1001/archgenpsychiatry.2011.129
  51. Fowler D, Garety PA, Kuipers E. Cognitive behaviour therapy for psychosis. Theory and practice. Chichester: Wiley, 1995.
  52. Bellack A.S. Schizophrenia: Behavior therapy's forgotten child. Behavior Therapy. 1986;17(3):199-214. https://doi.org/10.1016/S0005-7894(86)80051-X.
  53. Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, Landau S. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res. 2005 Sep 15;77(2-3):201-10. doi: 10.1016/j.schres.2005.03.013
  54. Birchwood M, Peters E, Tarrier N, Dunn G, Lewis S, Wykes T, Davies L, Lester H, Michail M. A multi-centre, randomised controlled trial of cognitive therapy to prevent harmful compliance with command hallucinations. BMC Psychiatry. 2011 Sep 30;11:155. doi: 10.1186/1471-244X-11-155
  55. Trower P, Birchwood M, Meaden A, Byrne S, Nelson A, Ross K. Cognitive therapy for command hallucinations: randomised controlled trial. Br J Psychiatry. 2004 Apr;184:312-20. doi: 10.1192/bjp.184.4.312
  56. Gottlieb J.D., Romeo K.H., Penn D.L., Mueser K.T., Chiko B.P. Web-based cognitive-behavioral therapy for auditory hallucinations in persons with psychosis: A pilot study. Schizophr Res. 2013. Vol. 145. No. 1–3. P. 82–87. DOI: 10.1016/j.schres.2013.01.002.
  57. Freeman D, Dunn G, Startup H, Pugh K, Cordwell J, Mander H, Černis E, Wingham G, Shirvell K, Kingdon D. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry. 2015 Apr;2(4):305-13. doi: 10.1016/S2215-0366(15)00039-5
  58. Staring AB, Ter Huurne MA, van der Gaag M. Cognitive Behavioral Therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. J Behav Ther Exp Psychiatry. 2013 Sep;44(3):300-6. doi: 10.1016/j.jbtep.2013.01.004
  59. Klingberg S, Wölwer W, Engel C, Wittorf A, Herrlich J, Meisner C, Buchkremer G, Wiedemann G. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr Bull. 2011 Sep;37 Suppl 2(Suppl 2):S98-110. doi: 10.1093/schbul/sbr073
  60. Comprehensive care of schizophrenia: A textbook of clinical management /ed. by JA Lieberman, RM Murray. London: Martin Dunitz, 2000:256.
  61. Anthony PF, Morrison P. Early detection and cognitive therapy for people at high risk of developing psychosis: A treatment approach. John Wiley & Sons Ltd., 2004. DOI: 10.1002/9780470713259
  62. Morrison A.P. The interpretation of intrusions in psychosis: An integrative cognitive approach to hallucinations and delusions. Behavioral and Cognitive Psychotherapy. 2001 July;29(3):257–276. https://doi.org/10.1017/S1352465801003010
  63. Kingdon D, Turkington D. Cognitive behavioral therapy of schizophrenia. Hove: Lawrence Erlbaum Associates, 1994:212.
  64. Strauss JS. Hallucinations and delusions as points on continua function. Rating scale evidence. Arch Gen Psychiatry. 1969 Nov;21(5):581-6. doi: 10.1001/archpsyc.1969.01740230069010
  65. Clark HH. Using language. N.Y.: Cambridge University Press, 1996.
  66. Salkovskis PM. Avoidance behaviour is motivated by threat beliefs: A possible resolution ofthe cognitive-behaviour debate. In: Salkovskis PM. (ed.). Trends in cognitive and behavioural therapies. Chichester: Wiley, 1996:25-42.
  67. Wells A. Meta-cognition and worry: A cognitive model of generalized anxiety disorder. Behavioural and Cognitive Psychotherapy. 1995;23(3):301-20. doi:10.1017/S1352465800015897
  68. Mrazek P.J., Haggerty R.J. (eds). Reducing risks for mental disorders: Frontiers for preventive intervention research. Washington, DC: National Academies Press, 1994.
  69. Birchwood M, Smith J, Macmillan F, Hogg B, Prasad R, Harvey C, Bering S. Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychol Med. 1989 Aug;19(3):649-56. doi: 10.1017/s0033291700024247
  70. Chadwick PD, Birchwood MJ, Trower P. Wiley series in clinical psychology. Cognitive therapy for delusions, voices and paranoia. John Wiley & Sons, 1996.
  71. Gumley A., Power K. Is targeting cognitive therapy during relapse in psychosis feasible? Behavioural and Cognitive Psychotherapy. 2000 April;28(2):161-74. doi: 10.1017/S1352465800001077
  72. Gumley A.I., White C.A., Power K.G. An interacting cognitive subsystems model of relapse and course of psychosis. Clinical Psychology and Psychotherapy. 1999 October;6(4):261-78. doi:10.1002/(SICI)1099-0879(199910)6:4<261::AID-CPP211>3.0.CO;2-C
  73. van der Gaag M, Nieman DH, Rietdijk J, Dragt S, Ising HK, Klaassen RM, Koeter M, Cuijpers P, Wunderink L, Linszen DH. Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophr Bull. 2012 Nov;38(6):1180-8. doi: 10.1093/schbul/sbs105
  74. Rietdijk J, Dragt S, Klaassen R, Ising H, Nieman D, Wunderink L, Delespaul P, Cuijpers P, Linszen D, van der Gaag M. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial. Trials. 2010 Mar 22;11:30. doi: 10.1186/1745-6215-11-30
  75. Beck AT, Finkel MR, Beck JS. The theory of modes: Applications to schizophrenia and other psychological conditions. Cogn Ther Res. 2020. https://doi.org/10.1007/s10608-020-10098-0
  76. Beck A.T. The recovery-oriented cognitive therapy (CT-R) difference: Activating positive cognitions rather than deactivating negative cognitions. 2020 April 28. https://beckinstitute.org/the-recovery-oriented-cognitive-therapy-difference/
  77. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res. 2011 Jan;125(1):54-61. doi: 10.1016/j.schres.2010.10.015
  78. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002 Oct;59(10):921-8. doi: 10.1001/archpsyc.59.10.921
  79. Berger G, Fraser R, Carbone S, McGorry P. Emerging psychosis in young people - Part 1 - key issues for detection and assessment. Aust Fam Physician. 2006 May;35(5):315-21. PMID: 16680211
  80. Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Schizophr Bull. 2011 Jan;37(1):21-2. doi: 10.1093/schbul/sbq138
  81. Basan A, Pitschel-Walz G, Bäuml J. Psychoedukative Gruppen bei schizophrenen Patienten und anschliessende ambulante Langzeitbehandlung. Eine 4-Jahres-Katamnese und Literaturübersicht [Psychoeducational intervention for schizophrenic patients and subsequent long-term ambulatory care. A four-year follow-up]. Fortschr Neurol Psychiatr. 2000 Dec;68(12):537-45. German. doi: 10.1055/s-2000-10038
  82. Bisbee C.C., Vickar G.M. A review of psychoeducation for patients with schizophrenia. Psychiatric Annals. 2012 June;42:205-10. doi:10.3928/00485713-20120606-03
  83. NICE 2019. All rights reserved. Subject to Notice of rights. URL: https://www.nice.org.uk/terms-and-Page46conditions#notice-of-right. Last updated: March 2014.
  84. Pharoah FM, Rathbone J, Mari JJ, Streiner D. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2003;(4):CD000088. doi: 10.1002/14651858
  85. Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD000088. doi: 10.1002/14651858.CD000088.pub2
  86. McFarlane WR, Dixon L, Lukens E, Lucksted A. Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther. 2003 Apr;29(2):223-45. doi: 10.1111/j.1752-0606.2003.tb01202.x
  87. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996 Feb 10;312(7027):345-9. doi: 10.1136/bmj.312.7027.345
  88. Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol. 1985 Oct;53(5):666-71. doi: 10.1037//0022-006x.53.5.666
  89. Holzer L, Urben S, Passini CM, Jaugey L, Herzog MH, Halfon O, Pihet S. A randomized controlled trial of the effectiveness of computer-assisted cognitive remediation (CACR) in adolescents with psychosis or at high risk of psychosis. Behav Cogn Psychother. 2014 Jul;42(4):421-34. doi: 10.1017/S1352465813000313
  90. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011 May;168(5):472-85. doi: 10.1176/appi.ajp.2010.10060855
  91. Keshavan MS, Vinogradov S, Rumsey J, Sherrill J, Wagner A. Cognitive training in mental disorders: update and future directions. Am J Psychiatry. 2014 May;171(5):510-22. doi: 10.1176/appi.ajp.2013.13081075